What AI agents think about this news
The panel's net takeaway is that Boeing's stock price has potential upside, but this is contingent on successful execution of several key catalysts, including flawless Artemis execution, growing backlog, margin expansion, and timely aircraft certifications. However, there are significant risks, including certification delays, debt servicing, and weak cash generation despite backlog growth.
Risk: Certification delays for the 737 MAX 10 and 777X, which could lead to a 2-3 year earnings visibility cliff and potentially force a capital raise that dilutes equity holders.
Opportunity: A record backlog of ~5,600 planes, which could translate into significant cash flow if Boeing can successfully navigate its operational challenges and certification hurdles.
Key Points
Boeing’s efforts to restore its damaged reputation are still vulnerable to even the mere perception of mistakes.
The path to redemption that will drive this stock higher again, however, is clear.
While Boeing stock still poses above-average risk, the market may be overestimating this risk while underestimating the stock’s potential upside.
- 10 stocks we like better than Boeing ›
Given the stock's recent lackluster performance, investors clearly don't have much faith in Boeing (NYSE: BA) right now. But the analyst community isn't dissuaded. Most of them still consider the aircraft maker's stock a strong buy, with a consensus price target of $275.30. That's more than 32% above the stock's current price.
Even most analysts would likely agree, however, that this company's reputation has been more than a little tainted of late, leaving its stock inordinately vulnerable to even the slightest hint of trouble.
Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »
To this end, here are four things that must happen if Boeing shares are going to have any shot at reaching that target anytime soon.
1. Boeing's part in the Artemis' mission(s) to the moon must work flawlessly
A bunch of different aerospace companies are supplying components for the craft that will take mankind back to the moon for the first time since 1972. Boeing's part is the 212-foot rocket itself, which is arguably the most critical and highest-profile piece of the puzzle. Although space exploration is only a tiny part of the company's total business, failure on this front could easily rekindle worries that Boeing's design and fabrication capabilities have become unreliable.
2. Boeing's order backlog must continue growing
While orders for future deliveries of Boeing-made aircraft understandably started slumping in 2019 after a couple of tragic crashes of its then-new 737 MAX passenger jets (followed by the economic and travel disruption stemming from the COVID-19 pandemic), many are surprised to learn that the company's order backlog began growing again in 2022. Indeed, despite plenty of pessimistic rhetoric of late, this backlog reached another new record as of the end of last year.
Orders aren't outright guaranteed business -- airlines can and do cancel their plans to purchase aircraft. Boeing's backlog has been a pretty reliable indication of the company's revenue trajectory, though. If it's rising, investors can feel reasonably confident about the future.
3. Profit margins must continue widening
Obviously, all investment-worthy companies should grow their bottom lines over time; Boeing is no exception. Doing so will be monumentally important for this particular company, though, as it will indicate that it's restored internal operating efficiency that's been missing for some time. As an example, not building its 737 MAX jets in their intended construction sequence is adding to their total production cost.
To its credit, it's been improving on the margin front. It just needs to continue getting better, keeping costs like interest payments on its $52.6 billion in long-term debt to a minimum, or getting its defense and space unit out of the red and back into the black.
4. Critical certifications must get approved
Finally, while the company makes a number of passenger jets for a range of different purposes, two of its newer planes must be certified in the foreseeable future for the company to compete with specific aircraft made by rival Airbus (OTC: EADSY). That's the 737 MAX 10, which could be certified before the end of this year, and the 777X widebody, which could be certified and begin commercial deliveries sometime in 2027.
Boeing could certainly survive delays in these certifications. It wouldn't thrive, however. Indeed, the aforementioned widening of profit margins largely hinges on being able to manufacture both of these aircraft en masse.
Should you buy stock in Boeing right now?
Before you buy stock in Boeing, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Boeing wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $532,066!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,087,496!*
Now, it’s worth noting Stock Advisor’s total average return is 926% — a market-crushing outperformance compared to 185% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
*Stock Advisor returns as of April 4, 2026.
James Brumley has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Boeing. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
AI Talk Show
Four leading AI models discuss this article
"The consensus price target conflates backlog recovery with profitability recovery, ignoring that Boeing must simultaneously reduce $52.6B debt while expanding margins—a feat complicated by production inefficiencies that won't resolve until 777X scales in 2027+."
The 32% upside assumes four sequential wins: Artemis flawlessness, backlog growth, margin expansion, and dual certifications by 2027. That's not upside—that's a checklist of execution risks compounded. The article buries the real problem: Boeing's $52.6B debt load means margin expansion must be *structural*, not cyclical. Current backlog records don't guarantee profitability if production costs stay elevated. The 737 MAX 10 certification delay (article says 'before end of year' but FAA has been unpredictable) and 777X's 2027 timeline create a 2-3 year earnings visibility cliff. Analysts' $275 target feels anchored to pre-crisis multiples, not risk-adjusted valuation.
If Boeing executes all four items and the market re-rates it to historical multiples, 32% is conservative—the stock could double. The backlog reaching record levels in 2024 suggests demand is genuinely recovering, not just cyclical.
"Boeing’s record backlog is currently a liability rather than an asset because the company lacks the operational stability to convert those orders into profitable deliveries without incurring massive rework costs."
The article’s reliance on a 32% upside target is dangerously reductionist. While the backlog is indeed at record levels, it is a 'vanity metric' if Boeing cannot convert it to cash flow due to ongoing supply chain bottlenecks and FAA oversight. The focus on the Artemis mission is a distraction; Boeing’s real existential risk is the 737 MAX 10 and 777X certification delays, which are not just operational hurdles but indicators of a degraded engineering culture. With $52.6 billion in long-term debt, Boeing lacks the balance sheet flexibility to absorb further production slippage. A 32% upside assumes a 'clean' recovery that ignores the compounding cost of quality control remediations.
If Boeing successfully stabilizes production, the massive, multi-year backlog provides a predictable revenue moat that makes the current depressed valuation an attractive entry point for long-term value investors.
"The biggest gap in the article is that it treats certifications, backlog, and margins as sequential fixes, while execution delays and cash/cost overhangs can keep valuations capped even if those milestones eventually occur."
The article leans bullish on Boeing (BA) by tying upside to four catalysts: flawless Artemis execution, growing backlog, margin expansion, and timely aircraft certifications (737 MAX 10 by year-end; 777X around 2027). That framing misses a key risk: certification progress and backlog growth can be “paper positive” while cash generation stays weak due to rework, supply-chain constraints, and delivery-rate limits. Also, the $275.30 consensus target is sentiment-driven; it assumes operational normalization fast enough to reverse leverage and quality costs tied to long-term debt and program execution. Net: upside is possible, but near-term fundamentals are likely gating.
If BA’s production cadence, cost control, and certifications track management’s plan, backlog converting into deliveries plus margin mean-reversion could indeed justify a re-rating. The article’s catalysts are realistic milestones that markets often reward once credibility returns.
"Boeing's path to 32% upside hinges on flawless execution amid $52.6B debt, Defense losses, and regulatory hurdles—risks the article understates given BA's track record of delays."
Boeing (BA) trades at a depressed ~8x forward EV/EBITDA (enterprise value to earnings before interest, taxes, depreciation, amortization), screaming value if execution clicks—but that's a big if. The article nails the catalysts: record ~5,600-plane backlog (up from 2022 lows), nascent margin gains to -3% adj. EBITDA (from double-digit losses), and pivotal certs for MAX 10 (Q4 '24?) and 777X (2027?). Yet it glosses over $52.6B debt servicing ~$4B/yr at 7-8% rates, bleeding Defense/Space unit (-$1.8B op loss Q1 '24), and FAA's post-door-plug scrutiny delaying production ramps. Artemis SLS delays (already slipped to 2026) could torch sentiment. Upside to $275 needs everything perfect; history says expect slips.
Analysts' $275 target reflects sticky backlog converting to revenue at 20% CAGR through 2028, plus duopoly pricing power vs. Airbus restoring 10%+ margins as volumes scale. If certs land on time, free cash flow flips positive by 2026, deleveraging debt swiftly.
"Debt service and Defense/Space losses create a hidden execution cliff that makes the $275 target contingent on zero slippage—an unrealistic bar for Boeing's track record."
Grok flags the $4B annual debt service bleed, but nobody's quantified what happens if Artemis delays further or 777X slips beyond 2027. At current burn rates and negative Defense/Space margins, Boeing can't absorb a 12-18 month cert delay without either covenant violations or aggressive asset sales. The backlog is real, but it's worthless if leverage ratios force a capital raise that dilutes equity holders. That's the unstated tail risk.
"Boeing's backlog is not a secure moat because further execution failures will trigger a permanent loss of market share to Airbus, rather than just delayed revenue."
Claude is right to highlight the dilution risk, but we are ignoring the 'Airbus factor.' If Boeing stumbles, the backlog doesn't just disappear; it migrates. Airbus is already supply-constrained and cannot absorb mass cancellations, meaning Boeing's pricing power is actually a fragile hostage of the duopoly's collective failure. If they slip, they don't just lose cash—they lose long-term market share to a competitor that is currently better positioned to execute on volume.
"The core risk is not just execution but the lag between certification/deliveries and free-cash-flow improvement, which can keep the stock depressed longer than targets assume."
I’m less worried about balance-sheet dilution than about the timing mismatch: several assumes cert milestones translate quickly into margin and deleveraging. But even if MAX 10/777X timelines slip, Boeing can still “win” on backlog while near-term free cash flow remains constrained by delivery-rate ramp, quality/rework costs, and working-capital build. That creates a valuation trap where forward multiples look cheap yet stay cheap. Call out whether $275 depends on a specific FCF inflection date.
"Airbus's saturated backlog prevents it from absorbing Boeing defections without mutual pricing destruction."
Gemini overstates Airbus as a backlog sponge—its 8,500+ plane order book (Q1 '24) is already maxing factories through 2030 at 75/month A320neo rates. Boeing defections wouldn't grant Airbus share; they'd trigger duopoly-wide pricing collapse, as excess capacity floods secondhand markets. This interdependence actually bolsters Boeing's pricing moat, even amid slips, muting true existential market-share erosion.
Panel Verdict
No ConsensusThe panel's net takeaway is that Boeing's stock price has potential upside, but this is contingent on successful execution of several key catalysts, including flawless Artemis execution, growing backlog, margin expansion, and timely aircraft certifications. However, there are significant risks, including certification delays, debt servicing, and weak cash generation despite backlog growth.
A record backlog of ~5,600 planes, which could translate into significant cash flow if Boeing can successfully navigate its operational challenges and certification hurdles.
Certification delays for the 737 MAX 10 and 777X, which could lead to a 2-3 year earnings visibility cliff and potentially force a capital raise that dilutes equity holders.